Overview

Dose-finding and Safety Study of SHR4640 in Subjects With Hyperuricemia

Status:
Completed
Trial end date:
2018-07-20
Target enrollment:
Participant gender:
Summary
The objective of the study is to assess efficacy and safety of SHR4640 in subjects with hyperuricemia.
Phase:
Phase 2
Details
Lead Sponsor:
Jiangsu HengRui Medicine Co., Ltd.
Treatments:
Benzbromarone